Grall, Maximilien
Daviet, Florence
Chiche, Noémie Jourde
Provot, François
Presne, Claire
Coindre, Jean-Philippe
Pouteil-Noble, Claire
Karras, Alexandre
Guerrot, Dominique
François, Arnaud
Benhamou, Ygal
Veyradier, Agnès
Frémeaux-Bacchi, Véronique
Coppo, Paul
Grangé, Steven
Article History
Received: 7 February 2021
Accepted: 1 July 2021
First Online: 21 July 2021
Declarations
:
: All patients and/or parents/guardians provided written informed consent for entry into the current study. This study was approved by our institutional review board (Rouen University Hospital) in accordance with the Declaration of Helsinki, and the French Data Protection Authority (“Commission Nationale Informatique et Libertés,” CNIL, authorization n°911,539, and “Comité consultatif sur le traitement de l’information en matière de recherche dans le domaine de la santé,” CCTIRS, authorization n°11.537, Paris, France).
: Not applicable.
: PC, SG and VFB are members of the Clinical Advisory Board for Alexion. PC and YG are members of the Clinical Advisory Board for Sanofi and Octapharma. PC received financings from Roche Pharma. SG received grants from Alexion.